Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Cefotetan disodium
Drug ID BADD_D00392
Description A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.
Indications and Usage For prophylaxis and treatment of bacterial infections.
Marketing Status approved
ATC Code J01DC05
DrugBank ID DB01330
KEGG ID D02228
MeSH ID D015313
PubChem ID 53024
TTD Drug ID D0AP9T
NDC Product Code 63323-386; 63323-385; 52946-0834
UNII 0GXP746VXB
Synonyms Cefotetan | Apatef | Cefotetan Disodium | Disodium, Cefotetan | Cefotetan Disodium Salt | Disodium Salt, Cefotetan | Salt, Cefotetan Disodium | ICI-156834 | ICI 156834 | ICI156834 | YM-09330 | YM 09330 | YM09330 | Apacef | Ceftotan | Cefotan
Chemical Information
Molecular Formula C17H15N7Na2O8S4
CAS Registry Number 74356-00-6
SMILES CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)[O-])S4)OC)SC2)C(=O)[O- ].[Na+].[Na+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Agranulocytosis01.02.03.001---
Alanine aminotransferase increased13.03.04.005--
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactic shock10.01.07.002; 24.06.02.004---
Aplastic anaemia01.03.03.002---
Aspartate aminotransferase increased13.03.04.011--
Blood bilirubin increased13.03.04.018--
Blood creatinine13.13.01.020---
Blood lactate dehydrogenase increased13.04.02.002--
Blood urea increased13.13.01.006---
Body temperature increased13.15.01.001---
Cholestasis09.01.01.001---
Colitis07.08.01.001--
Complications of transplanted liver09.01.08.011; 12.02.09.014---
Coombs direct test positive13.01.01.001---
Dermatitis23.03.04.002---
Diarrhoea07.02.01.001--
Discomfort08.01.08.003---
Eosinophilia01.02.04.001--
Erythema multiforme10.01.03.015; 23.03.01.003--
Gastrointestinal pain07.01.05.005--
Haemoglobin13.01.05.018---
Haemolytic anaemia01.06.03.002---
Hepatic function abnormal09.01.02.001---
Hypersensitivity10.01.03.003--
Injection site phlebitis08.02.03.011; 12.07.03.012; 24.12.03.003---
Leukopenia01.02.02.001---
Nausea07.01.07.001--
Nephropathy toxic12.03.01.010; 20.05.03.002---
The 1th Page    1 2    Next   Last    Total 2 Pages